Optometry and Vision Science · 2003 · 75 citations · 8 references
MedicineOncologyOphthalmologyChemotherapyClinical Vision ScienceOcular DiseaseFluorescein AngiographyMacular DisordersAntineoplastic HormonesCapillary Permeability ChangesDrug-induced Ocular ToxicityFluorescein Angiography Findings
BACKGROUND: Cystic maculopathy without leakage on fluorescein angiography has been described in cases of toxicity to niacin. We present a similar case of cystic maculopathy due to docetaxel (Taxotere) in the treatment of breast cancer. CASE REPORT: A 53-year-old Asian female presented with complaints of decreased vision soon after the initiation of treatment for breast cancer with docetaxel. A cystic maculopathy with a normal fluorescein angiogram was found on examination. Significant improvement in visual acuity along with resolution of the cystic maculopathy was found after changing to an alternate antineoplastic agent. CONCLUSION: Docetaxel may be associated with cystic maculopathy that does not display angiographic evidence of abnormal capillary permeability.
8
Docetaxel Administered on a Weekly Basis for Metastatic Breast Cancer
Harold J. Burstein, Judith Manola, Jerry Younger et al. · Journal of Clinical Oncology · 2000 · 261 citations
Medicine, Oncology, Pharmacotherapy +16
Martine Piccart, J.G.M. Klijn, Robert Paridaens et al. · Journal of Clinical Oncology · 1997 · 162 citations
Medicine, Oncology, Pharmacology +16
Canalicular stenosis secondary to docetaxel (taxotere)
Bita Esmaeli, Vicente Valero, Moloud Ahmadi et al. · Ophthalmology · 2001 · 145 citations
J. Donald M. Gass · American Journal of Ophthalmology · 1973 · 112 citations